BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 30589872)

  • 21. Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts.
    Johnson LA; Rodansky ES; Sauder KL; Horowitz JC; Mih JD; Tschumperlin DJ; Higgins PD
    Inflamm Bowel Dis; 2013 Apr; 19(5):891-903. PubMed ID: 23502354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
    Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
    Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptomic identification of TMIGD1 and its relationship with the ileal epithelial cell differentiation in Crohn's disease.
    Zabana Y; Lorén V; Domènech E; Aterido A; Garcia-Jaraquemada A; Julià A; Vicario M; Pedrosa E; Ferreiro M; Troya J; Lozano JJ; Sarrias MR; Cabré E; Mañosa M; Manyé J
    Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G109-G120. PubMed ID: 32508154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease.
    Wehkamp J; Schmid M; Fellermann K; Stange EF
    J Leukoc Biol; 2005 Apr; 77(4):460-5. PubMed ID: 15618294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease.
    Zakrzewski M; Simms LA; Brown A; Appleyard M; Irwin J; Waddell N; Radford-Smith GL
    J Crohns Colitis; 2019 Mar; 13(4):451-461. PubMed ID: 30445599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease.
    Stallmach A; Schuppan D; Riese HH; Matthes H; Riecken EO
    Gastroenterology; 1992 Jun; 102(6):1920-9. PubMed ID: 1587410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
    Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
    Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-defensins (α-Defs) in Crohn's disease: decrease of ileal α-Def 5 via permanent methylation and increase in plasma α-Def 1-3 concentrations offering biomarker utility.
    Cerrillo E; Moret I; Iborra M; Ramos D; Busó E; Tortosa L; Sáez-González E; Nos P; Beltrán B
    Clin Exp Immunol; 2018 Apr; 192(1):120-128. PubMed ID: 29193023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-Omics Characterization of Colon Mucosa and Submucosa/Wall from Crohn's Disease Patients.
    Jin L; Macoritto M; Wang J; Bi Y; Wang F; Suarez-Fueyo A; Paez-Cortez J; Hu C; Knight H; Mascanfroni I; Staron MM; Schwartz Sterman A; Houghton JM; Westmoreland S; Tian Y
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S100A4 expression is increased in stricture fibroblasts from patients with fibrostenosing Crohn's disease and promotes intestinal fibroblast migration.
    Cunningham MF; Docherty NG; Burke JP; O'Connell PR
    Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G457-66. PubMed ID: 20489045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate Myeloid Cell Subset-Specific Gene Expression Patterns in the Human Colon are Altered in Crohn's Disease Patients.
    Sekido Y; Yasumizu Y; Nishimura J; Kayama H; Matsuno H; Ogino T; Miyoshi N; Takahashi H; Haraguchi N; Hata T; Matsuda C; Doki Y; Mori M; Takeda K; Ohkura N; Sakaguchi S; Mizushima T
    Digestion; 2019; 99(3):194-204. PubMed ID: 30343293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of the TL1A/DcR3 system of TNF/TNFR-like proteins in large vs. small intestinal Crohn's disease.
    Bamias G; Kaltsa G; Siakavellas SI; Gizis M; Margantinis G; Zampeli E; Vafiadis-Zoumboulis I; Michopoulos S; Daikos GL; Ladas SD
    Dig Liver Dis; 2012 Jan; 44(1):30-6. PubMed ID: 21978578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered Expression of Angiotensinogen and Mediators of Angiogenesis in Ileal Crohn's Disease.
    Hume GE; Doecke JD; Huang N; Fowler EV; Brown IS; Simms LA; Radford-Smith GL
    J Gastrointestin Liver Dis; 2016 Mar; 25(1):39-48. PubMed ID: 27014752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon.
    Berrebi D; Maudinas R; Hugot JP; Chamaillard M; Chareyre F; De Lagausie P; Yang C; Desreumaux P; Giovannini M; Cézard JP; Zouali H; Emilie D; Peuchmaur M
    Gut; 2003 Jun; 52(6):840-6. PubMed ID: 12740340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenesis and Vascular Endothelial Growth Factor-A Expression Associated with Inflammation in Pediatric Crohn's Disease.
    Knod JL; Crawford K; Dusing M; Collins MH; Chernoguz A; Frischer JS
    J Gastrointest Surg; 2016 Mar; 20(3):624-30. PubMed ID: 26530519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormalities in mucin gene expression in Crohn's disease.
    Buisine MP; Desreumaux P; Debailleul V; Gambiez L; Geboes K; Ectors N; Delescaut MP; Degand P; Aubert JP; Colombel JF; Porchet N
    Inflamm Bowel Dis; 1999 Feb; 5(1):24-32. PubMed ID: 10028446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Fibroblast Activation Protein Restores a Balanced Extracellular Matrix and Reduces Fibrosis in Crohn's Disease Strictures Ex Vivo.
    Truffi M; Sorrentino L; Monieri M; Fociani P; Mazzucchelli S; Bonzini M; Zerbi P; Sampietro GM; Di Sabatino A; Corsi F
    Inflamm Bowel Dis; 2018 Jan; 24(2):332-345. PubMed ID: 29361086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in microRNA expression profiles in inflamed and noninflamed ascending colon mucosae of patients with active Crohn's disease.
    Wu LY; Ma XP; Shi Y; Bao CH; Jin XM; Lu Y; Zhao JM; Zhou CL; Chen D; Liu HR
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1706-1715. PubMed ID: 28261881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.